{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:29Z","timestamp":1707525089234},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,24]]},"DOI":"10.7759\/cureus.40908","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T02:57:09Z","timestamp":1687661829000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Study of Combination of Oral Tranexamic Acid With Modified Kligman\u2019s Formula Versus Oral Tranexamic Acid With Azelaic Acid 15% in the Treatment of Melasma"],"prefix":"10.7759","author":[{"given":"Riddhima","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhushan","family":"Madke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarshlata","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sugat","family":"Jawade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2668","article-title":"Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review","volume":"97","author":"Kim HJ","year":"2017","unstructured":"Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venereol. 2017, 97:776-81. 10.2340\/00015555-2668","journal-title":"Acta Derm Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12830","article-title":"Evaluation of oral tranexamic acid in the treatment of melasma","volume":"18","author":"Colferai MM","year":"2019","unstructured":"Colferai MM, Miquelin GM, Steiner D. Evaluation of oral tranexamic acid in the treatment of melasma. J Cosmet Dermatol. 2019, 18:1495-501. 10.1111\/jocd.12830","journal-title":"J Cosmet Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.0906-6705.2005.00337.x","article-title":"DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency","volume":"14","author":"Boissy RE","year":"2005","unstructured":"Boissy RE, Visscher M, DeLong MA. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol. 2005, 14:601-8. 10.1111\/j.0906-6705.2005.00337.x","journal-title":"Exp Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03251.x","article-title":"Melasma in Latin America: options for therapy and treatment algorithm","volume":"23","author":"Cestari T","year":"2009","unstructured":"Cestari T, Arellano I, Hexsel D, Ortonne JP. Melasma in Latin America: options for therapy and treatment algorithm. J Eur Acad Dermatol Venereol. 2009, 23:760-72. 10.1111\/j.1468-3083.2009.03251.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-013-0038-4","article-title":"Treatment of melasma with topical agents, peels and lasers: an evidence-based review","volume":"14","author":"Rivas S","year":"2013","unstructured":"Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol. 2013, 14:359-76. 10.1007\/s40257-013-0038-4","journal-title":"Am J Clin Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2012.01530.x","article-title":"Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma","volume":"25","author":"Figueiredo Souza L","year":"2012","unstructured":"Figueiredo Souza L, Trancoso Souza S. Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma. Dermatol Ther. 2012, 25:477-80. 10.1111\/j.1529-8019.2012.01530.x","journal-title":"Dermatol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.74545","article-title":"Mometasone-based triple combination therapy in melasma: is it really safe?","volume":"55","author":"Majid I","year":"2010","unstructured":"Majid I. Mometasone-based triple combination therapy in melasma: is it really safe?. Indian J Dermatol. 2010, 55:359-62. 10.4103\/0019-5154.74545","journal-title":"Indian J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363130-00008","article-title":"Tranexamic acid: a review of its use in the management of menorrhagia","volume":"63","author":"Wellington K","year":"2003","unstructured":"Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs. 2003, 63:1417-33. 10.2165\/00003495-200363130-00008","journal-title":"Drugs"},{"key":"ref9","article-title":"Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies","volume":"57","author":"Breathnach AS","year":"1996","unstructured":"Breathnach AS. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. Cutis. 1996, 57:36-45.","journal-title":"Cutis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i58A34132","article-title":"Comparative study of combination of oral tranexamic acid with modified Kligman\u2019s formula versus oral tranexamic acid with azelaic acid 15% in the treatment of melasma","volume":"412","author":"Singh R","year":"2021","unstructured":"Singh R, Maheshwari P. Comparative study of combination of oral tranexamic acid with modified Kligman\u2019s formula versus oral tranexamic acid with azelaic acid 15% in the treatment of melasma. J Pharm Res Int. 2021, 412:8. 10.9734\/jpri\/2021\/v33i58A34132","journal-title":"J Pharm Res Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.26722","article-title":"Scoring systems in dermatology","volume":"72","author":"Bhor U","year":"2006","unstructured":"Bhor U, Pande S. Scoring systems in dermatology. Indian J Dermatol Venereol Leprol. 2006, 72:315-21. 10.4103\/0378-6323.26722","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref12","article-title":"A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore","volume":"40","author":"Goh CL","year":"1999","unstructured":"Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999, 40:455-8.","journal-title":"Singapore Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.84722","article-title":"Melasma: a clinico-epidemiological study of 312 cases","volume":"56","author":"Achar A","year":"2011","unstructured":"Achar A, Rathi SK. Melasma: a clinico-epidemiological study of 312 cases. Indian J Dermatol. 2011, 56:380-2. 10.4103\/0019-5154.84722","journal-title":"Indian J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1995.01690240119022","article-title":"Melasma: etiologic and therapeutic considerations","volume":"131","author":"Grimes PE","year":"1995","unstructured":"Grimes PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol. 1995, 131:1453-7. 10.1001\/archderm.1995.01690240119022","journal-title":"Arch Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/09546630601028778","article-title":"Melasma and its impact on health-related quality of life in Hispanic women","volume":"18","author":"Pawaskar MD","year":"2007","unstructured":"Pawaskar MD, Parikh P, Markowski T, McMichael AJ, Feldman SR, Balkrishnan R. Melasma and its impact on health-related quality of life in Hispanic women. J Dermatolog Treat. 2007, 18:5-9. 10.1080\/09546630601028778","journal-title":"J Dermatolog Treat"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-011-1135-1","article-title":"OPRM1 and EGFR contribute to skin pigmentation differences between Indigenous Americans and Europeans","volume":"131","author":"Quillen EE","year":"2012","unstructured":"Quillen EE, Bauchet M, Bigham AW, et al.. OPRM1 and EGFR contribute to skin pigmentation differences between Indigenous Americans and Europeans. Hum Genet. 2012, 131:1073-80. 10.1007\/s00439-011-1135-1","journal-title":"Hum Genet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.001","article-title":"Melasma: a comprehensive update: part II","volume":"65","author":"Sheth VM","year":"2011","unstructured":"Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. J Am Acad Dermatol. 2011, 65:699-714. 10.1016\/j.jaad.2011.06.001","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1975.01630130042004","article-title":"A new formula for depigmenting human skin","volume":"111","author":"Kligman AM","year":"1975","unstructured":"Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975, 111:40-8. 10.1001\/archderm.1975.01630130042004","journal-title":"Arch Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32133.x","article-title":"Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial","volume":"32","author":"Lee JH","year":"2006","unstructured":"Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, Park YM. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg. 2006, 32:626-31. 10.1111\/j.1524-4725.2006.32133.x","journal-title":"Dermatol Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2012.685478","article-title":"Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial","volume":"14","author":"Kanechorn Na Ayuthaya P","year":"2012","unstructured":"Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther. 2012, 14:150-4. 10.3109\/14764172.2012.685478","journal-title":"J Cosmet Laser Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-012-9899-9","article-title":"Treatment of melasma with oral administration of tranexamic acid","volume":"36","author":"Wu S","year":"2012","unstructured":"Wu S, Shi H, Wu H, Yan S, Guo J, Sun Y, Pan L. Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg. 2012, 36:964-70. 10.1007\/s00266-012-9899-9","journal-title":"Aesthetic Plast Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159990-comparative-study-of-combination-of-oral-tranexamic-acid-with-modified-kligmans-formula-versus-oral-tranexamic-acid-with-azelaic-acid-15-in-the-treatment-of-melasma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:02Z","timestamp":1707509102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159990-comparative-study-of-combination-of-oral-tranexamic-acid-with-modified-kligmans-formula-versus-oral-tranexamic-acid-with-azelaic-acid-15-in-the-treatment-of-melasma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.40908","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,24]]}}}